The targeting and modulation of G-protein-coupled receptors (GPCRs) has immense therapeutic potential. A study in Nature now reports on the successful targeting of intracellular allosteric sites that effectively bias GPCR signaling, which has opened new opportunities to develop safer therapeutic agents.
References
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B. & Gloriam, D. E. Nat. Rev. Drug Discov. 16, 829–842 (2017).
Ortiz Zacarías, N. V., Lenselink, E. B., IJzerman, A. P., Handel, T. M. & Heitman, L. H. Trends Pharmacol. Sci. 39, 547–559 (2018).
Powers, A. S. et al. Nat. Chem. Biol. 19, 805–814 (2023).
Chan, H. C. S., Li, Y., Dahoun, T., Vogel, H. & Yuan, S. Trends Biochem. Sci. 44, 312–330 (2019).
Katritch, V., Cherezov, V. & Stevens, R. C. Trends Pharmacol. Sci. 33, 17–27 (2012).
Kobayashi, K. et al. Nature 618, 1085–1093 (2023).
Baidya, M., Dwivedi, H. & Shukla, A. K. Nat. Struct. Mol. Biol. 24, 500–502 (2017).
Kumari, P., Inoue, A., Chapman, K., Lian, P. & Rosenbaum, D. M. Proc. Natl Acad. Sci. USA 120, e2219569120 (2023).
Mullard, A. Nat. Rev. Drug Discov. 22, 347–348 (2023).
Smith, J. S., Lefkowitz, R. J. & Rajagopal, S. Nat. Rev. Drug Discov. 17, 243–260 (2018).
Acknowledgements
The research program in M.B.’s laboratory is supported by the India Alliance DBT Wellcome Trust (IA/E/20/1/505691) and the Institute Seed Grant (SGT-100081) Indian Institute of Technology Jammu.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Soni, N., Das, T. & Baidya, M. Structural insights into an intracellular biased agonist for GPCRs. Nat Struct Mol Biol 30, 1612–1614 (2023). https://doi.org/10.1038/s41594-023-01100-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41594-023-01100-w
- Springer Nature America, Inc.